Data derived from PhenomiR
| PubMed ID | disease | disease class | tissue | expression | foldchange max | foldchange min | genes | study design | method |
| 18607389 |
Colorectal cancer - 114500 |
Cancer |
colorectum |
miRNA overexpression |
- |
1.4 |
- |
Patient study phenotype-control |
quantitative PCR
|
| 18433021 |
Hepatocellular carcinoma - 114550 |
Cancer |
liver |
miRNA downregulation |
- |
- |
- |
Patient study phenotype-control |
miRNA microarray
|
| 17616664 |
Hepatocellular carcinoma - 114550 |
Cancer |
liver |
miRNA downregulation |
- |
1.59 |
CCNG1 |
Patient study phenotype-phenotype |
miRNA microarray
|
| 18379589 |
Melanoma and neural system tumor syndrome - 155755 |
Cancer |
melanocyte |
miRNA downregulation |
- |
1.3 |
- |
Patient study phenotype-control |
quantitative PCR
|
| 18176954 |
Hepatocellular carcinoma - 114550 |
Cancer |
liver |
miRNA downregulation |
- |
1.67 |
- |
Patient study phenotype-phenotype |
miRNA microarray
|
| 16461460 |
Breast cancer - 114480 |
Cancer |
breast |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
miRNA microarray
|
| 18270258 |
Thyroid carcinoma, papillary - 188550 |
Cancer |
thyroid gland |
miRNA overexpression |
- |
8.9 |
- |
Patient study phenotype-control |
quantitative PCR
|
| 16103053 |
Breast cancer - 114480 |
Cancer |
breast |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
miRNA microarray
|
| 16103053 |
Breast cancer - 114480 |
Cancer |
HS578 cell |
miRNA overexpression |
- |
- |
- |
Cell culture study |
miRNA microarray
|
| 18560586 |
Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) |
Cancer |
OVCA-420 cell |
miRNA downregulation |
- |
2.27273 |
- |
Cell culture study |
miRNA microarray
|
| 18433021 |
Hepatic adenoma - 142330 |
Cancer |
liver |
miRNA downregulation |
- |
- |
- |
Patient study phenotype-control |
miRNA microarray
|
| 18381414 |
Squamous cell carcinoma, head and neck - 601400 (Oral squamous carcinoma (OSCC) - 0) |
Cancer |
HSC-3 cell |
miRNA downregulation |
- |
- |
- |
Cell culture study |
quantitative PCR
|
| 17222355 |
- |
- |
cell culture |
miRNA downregulation |
- |
13.54 |
- |
Bioprocess study |
miRNA microarray
|
| 18555017 |
Hepatocellular carcinoma - 114550 |
Cancer |
SNU-423 cell |
miRNA downregulation |
- |
- |
- |
Cell culture study |
miRNA microarray
|
| 17622355 |
Psoriasis, susceptibility to - 177900 |
Dermatological |
skin |
miRNA downregulation |
- |
5.55556 |
- |
Patient study phenotype-control |
miRNA microarray
|
| 17622355 |
Dermatitis, atopic - 603165 |
Dermatological |
skin |
miRNA downregulation |
- |
2.75 |
- |
Patient study phenotype-control |
miRNA microarray
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
T-47D cell |
miRNA downregulation |
- |
12.5 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
SK-BR-3 cell |
miRNA downregulation |
- |
5.55556 |
- |
Cell culture study |
quantitative PCR
|
| 18307259 |
Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) |
Cancer |
liver |
miRNA overexpression |
- |
2.0 |
- |
Patient study phenotype-control |
quantitative PCR
|
| 16754881 |
Ovarian cancer - 604370 |
Cancer |
ovary |
miRNA downregulation |
- |
- |
- |
Patient study phenotype-control |
array CGH
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
MCF-7 cell |
miRNA downregulation |
- |
4.0 |
- |
Cell culture study |
quantitative PCR
|
| 17922033 |
Cancer - 0 (Leiomyosarcoma - 0) |
Cancer |
muscle |
miRNA overexpression |
- |
93.05 |
- |
Patient study phenotype-control |
quantitative PCR
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-231 cell |
miRNA downregulation |
- |
4.54545 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-361 cell |
miRNA downregulation |
- |
2.12766 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Prostate cancer - 176807 |
Cancer |
PC-3 cell |
miRNA downregulation |
- |
20.0 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Prostate cancer - 176807 |
Cancer |
PPC-1 cell |
miRNA downregulation |
- |
33.3333 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Prostate cancer - 176807 |
Cancer |
DU-145 cell |
miRNA downregulation |
- |
5.88235 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Prostate cancer - 176807 |
Cancer |
LNCaP cell |
miRNA downregulation |
- |
7.14286 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
5.88235 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
5.0 |
- |
Cell culture study |
quantitative PCR
|
| 18766170 |
Lung cancer - 211980 |
Cancer |
serum |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
deep sequencing
|
| 16192569 |
Pancreatic cancer - 260350 |
Cancer |
PANC-1 cell |
miRNA downregulation |
- |
2.04082 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Lung cancer - 211980 |
Cancer |
lung cancer cell line |
miRNA downregulation |
- |
6.25 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Hematological - 0 |
Hematological |
K-562 cell |
miRNA downregulation |
- |
1.6129 |
- |
Cell culture study |
quantitative PCR
|
| 18607389 |
- |
- |
embryo |
miRNA overexpression |
- |
1.82 |
- |
Bioprocess study |
quantitative PCR
|
| 16192569 |
Lung cancer - 211980 |
Cancer |
A-549 cell |
miRNA downregulation |
- |
4.54545 |
- |
Cell culture study |
quantitative PCR
|
